abstract |
The present invention relates to the use of novel macrocyclic compounds of Formula I, n nwherein the variables Q, Q 1 , Q 2 , Q 3 , and Q 4 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases. |